there is no place for any surgical complacency with the nationwide incidence of retained stones remaining in the region of 10%, the benefit of operative choledochoscopy is perhaps less than fairly treated. He quotes Rattner with an incidence of 6% and Feliciano3 with an incidence of 8.9% retained stones. Do these two series represent some lychees among his apples and oranges?
Rattner reported eight retained stones in 144 patients -5-6, not 6%. In two of these patients, however, the stones were visualised with the choledochoscope but were not removed; the failure rate of choledochoscopy was thus six of 144 patients -4.2%. Feliciano found seven patients with retained stones in 79 patients -8.9%. We have recently reviewed the published literature on choledochoscopy, with clarification of the number of stone positive bile duct explorations by correspondence with the authors where necessary. In a total of 37 reports on operative choledochoscopy retained stones occurred in 99 of 3159 patients -less than 3*1%. Feliciano's report was one of only five papers in which the incidence of retained stones exceeded 5%. 4 Few surgeons resent the contribution that endoscopic sphincterotomy has made to the care of patients with common bile duct stones and the early experience of dealing with symptomatic common duct stones endoscopically in patients with gall bladders in situ is of great interest. Although these patients may now represent 50% of patients undergoing endoscopic sphincterotomy they do, of course, represent only a proportion of the 12% patients with gall stone disease who have stones in the bile duct as well as the gall bladder.
We entirely agree that endoscopic treatment should be used more widely. We inject intravariceally, however, and stop the injection when any blanching of the mucosa occurs. It is not surprising that the paravasal technique produces strictures as it has its effect on the varices by producing surrounding fibrosis. Intravariceal injection produces thrombosis of the vessels and the mucosa is affected only when inadvertent extravariceal injection occurs.
Intravariceal injections can be made without giving a high risk of variceal rebleeding (our risk being 0.065 bleeds per patient month of follow up). As the authors suggest, a controlled trial might be indicated, but this would not seem justified if aggressive paravasal injections give such a high incidence of complications.
